학술논문
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
1477092X